SciELO - Scientific Electronic Library Online

 
vol.56 número2KPC and VIM producing Enterobacter cloacae strain from a Hospital in Northeastern VenezuelaMecanismos patogénicos en el desarrollo de la esclerosis múltiple: ambiente, genes, sistema inmune y estrés oxidativo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Investigación Clínica

versión impresa ISSN 0535-5133

Resumen

OSUNA-ZAZUETA, Marcela Amparo; PONCE-GOMEZ, Juan Antonio  y  PEREZ-NERI, Iván. Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders. Invest. clín [online]. 2015, vol.56, n.2, pp.188-200. ISSN 0535-5133.

One of the most important causes of morbidity and mortality is neurologic dysfunction; its high incidence has led to an intense research of the mechanisms that protect the central nervous system from hypoxia and ischemia. The mayor challenge is to block the biochemical events leading to neuronal death. This may be achieved by neuroprotective mechanisms that avoid the metabolic and immunologic cascades that follow a neurological damage. When it occurs, several pathophysiological events develop including cytokine release, oxidative stress and excitotoxicity. Neuroprotective effects of cannabinoids to all those mechanisms have been reported in animal models of brain ischemia, excitotoxicity, brain trauma and neurodegenerative disorders. Some endocannabinoid analogs are being tested in clinical studies (I-III phase) for acute disorders involving neuronal death (brain trauma and ischemia). The study of the cannabinoid system may allow the discovery of effective neuroprotective drugs for the treatment of neurological disorders.

Palabras clave : cannabinoids; neuronal death; neuroprotection.

        · resumen en Español     · texto en Español